Testing Strategies for Metabolite-Mediated Neurotoxicity
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26178338 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Julian Suess und 8 weiteren Autor:innen. Beteiligte Einrichtung: In Vitro Toxicology and Biomedicine, Dept Inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, 78457 Konstanz, Germany. Hauptthemen laut MEDLINE: Neurotoxicity Syndromes, Neurons, Toxicity Tests, Xenobiotics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union's Horizon 2020 research, BMBF, European Union’s Horizon 2020 research.
Abstract (Originalsprache)
Compounds, which rely on metabolism to exhibit toxicity, pose a challenge for next-generation risk assessment (NGRA). Since many of the currently available non-animal new approach methods (NAMs) lack metabolic activity, their use may lead to an underestimation of the true hazard to humans (false negative predictions). We explored here strategies to deal with metabolite-mediated toxicity in assays for developmental neurotoxicity. First, we present an overview of substances that may serve as potential positive controls for metabolite-related neurotoxicity. Then, we demonstrate, using the MitoMet (UKN4b) assay, which assesses the adverse effects of chemicals on neurites of human neurons, that some metabolites have a higher toxic potency than their parent compound. Next, we designed a strategy to integrate elements of xenobiotic metabolism into assays used for (developmental) neurotoxicity testing. In the first step of this approach, hepatic post-mitochondrial fractions (S9) were used to generate metabolite mixtures (“metabolisation module”). In the second step, these were applied to a NAM (exemplified by the UKN4b assay) to identify metabolite-mediated toxicity. We demonstrate the applicability and transferability of these approaches to other assays, by an exemplary study on the basis of the cMINC (UKN2) assay, another NAM of the developmental neurotoxicity in vitro battery. Based on the experience gained from these experiments, we discuss key issues to be addressed if this approach is to be used more broadly for NAM in the NGRA context.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- In Vitro Toxicology and Biomedicine, Dept Inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, 78457 Konstanz, Germany.
- Latvian Institute of Organic Synthesis, LV-1006 Riga, Latvia.
- Certara Predictive Technologies, Level 2-Acero, 1 Concourse Way, Sheffield S1 2BJ, UK.
- Center for Alternatives to Animal Testing in Europe (CAAT-Europe), University of Konstanz, 78457 Konstanz, Germany.
ORCID-Profile: Moritz Reinmoeller, Edgars Liepinsh, Nadine Dreser, Anna-Katharina Holzer, Marcel Leist
Förderung
- European Union's Horizon 2020 research
- BMBF
- European Union’s Horizon 2020 research
Zitieren
APA
Suess, J., Reinmoeller, M., Magel, V., Gukalova, B., Liepinsh, E., Gardner, I., Dreser, N., Holzer, A. K., & Leist, M. (2025). Testing Strategies for Metabolite-Mediated Neurotoxicity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178338
Vancouver
Suess J, Reinmoeller M, Magel V, Gukalova B, Liepinsh E, Gardner I, et al. Testing Strategies for Metabolite-Mediated Neurotoxicity. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178338
BibTeX
@article{Suess2025,
author = {Suess, Julian and Reinmoeller, Moritz and Magel, Viktoria and Gukalova, Baiba and Liepinsh, Edgars and Gardner, Iain and Dreser, Nadine and Holzer, Anna-Katharina and Leist, Marcel},
title = {Testing Strategies for Metabolite-Mediated Neurotoxicity},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26178338}
}
EUVIMED